4.6 Review

The Hypoxia-Adenosine Link during Intestinal Inflammation

期刊

JOURNAL OF IMMUNOLOGY
卷 200, 期 3, 页码 897-907

出版社

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1701414

关键词

-

资金

  1. International Anesthesia Research Society Mentored Research Award
  2. National Institutes of Health [P50-CA098258, DK056338, R01-DK097075, R01-HL098294, POI-HL114457, R01-DK082509, R01-HL109233, R01-DK109574, R01-HL119837, R01-HL133900]
  3. NATIONAL CANCER INSTITUTE [P50CA098258] Funding Source: NIH RePORTER
  4. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119837, R01HL109233, R01HL133900, P01HL114457, R01HL098294] Funding Source: NIH RePORTER
  5. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082509, R01DK109574, R01DK097075, P30DK056338] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Intestinal inflammation is a key element in inflammatory bowel disease and is related to a combination of factors, including genetics, mucosal barrier dysfunction, bacteria translocation, deleterious host-microbe interactions, and dysregulated immune responses. Over the past decade, it has been appreciated that these inflammatory lesions are associated with profound tissue hypoxia. Interestingly, an endogenous adaptive response under the control of hypoxia signaling is enhancement in adenosine signaling, which impacts these different endpoints, including promoting barrier function and encouraging anti-inflammatory activity. In this review, we discuss the hypoxia-adenosine link in inflammatory bowel disease, intestinal ischemia/reperfusion injury, and colon cancer. In addition, we provide a summary of clinical implications of hypoxia and adenosine signaling in intestinal inflammation and disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据